|
🐜
|
Rosuvastatin and cardiovascular events in patients undergoing hemodialysis.
28 auth.
B. Fellström,
A. Jardine,
R. Schmieder,
H. Holdaas,
K. Bannister,
J. Beutler,
D. Chae,
A. Chevaile,
S. Cobbe,
C. Grönhagen‐Riska,
J. J. D. de Lima,
R. Lins,
G. Mayer,
Alan W. McMahon,
H. Parving,
...
G. Remuzzi,
O. Samuelsson,
S. Sonkodi,
D. Sci,
G. Süleymanlar,
D. Tsakiris,
V. Tesar,
V. Todorov,
A. Więcek,
R. Wüthrich,
Mattis Gottlow,
E. Johnsson,
F. Zannad
|
10 |
2009 |
10
🐜
|
|
🐢
|
Sirolimus and kidney growth in autosomal dominant polycystic kidney disease.
13 auth.
A. Serra,
Diane Poster,
A. Kistler,
F. Krauer,
Shagun Raina,
James Young,
K. Rentsch,
K. Spanaus,
O. Senn,
P. Kristanto,
...
H. Scheffel,
D. Weishaupt,
R. Wüthrich
|
9 |
2010 |
9
🐢
|
|
🐢
|
Inhibition of mTOR with sirolimus slows disease progression in Han:SPRD rats with autosomal dominant polycystic kidney disease (ADPKD).
P. Wahl,
A. Serra,
M. Le Hir,
Klaus D. Molle,
M. Hall,
R. Wüthrich
|
8 |
2006 |
8
🐢
|
|
🐜
|
CC chemokine receptor 5 and renal-transplant survival
14 auth.
M. Fischereder,
B. Luckow,
B. Hocher,
R. Wüthrich,
U. Rothenpieler,
H. Schneeberger,
U. Panzer,
R. Stahl,
I. Hauser,
K. Budde,
...
H. Neumayer,
B. Krämer,
W. Land,
D. Schlöndorff
|
8 |
2001 |
8
🐜
|
|
🐜
|
Secreted Klotho and FGF23 in chronic kidney disease Stage 1 to 5: a sequence suggested from a cross-sectional study.
10 auth.
I. Pavik,
P. Jaeger,
L. Ebner,
C. Wagner,
Katja Petzold,
Daniela Spichtig,
...
Diane Poster,
R. Wüthrich,
S. Russmann,
A. Serra
|
7 |
2013 |
7
🐜
|
|
🐢
|
Successful treatment of hypercalcemia with cinacalcet in renal transplant recipients with persistent hyperparathyroidism.
A. Serra,
A. Schwarz,
F. Wick,
H. Marti,
R. Wüthrich
|
7 |
2005 |
7
🐢
|
|
🐢
|
Mechanisms of Hyaluronan-Induced Up-Regulation of ICAM-1 and VCAM-1 Expression by Murine Kidney Tubular Epithelial Cells: Hyaluronan Triggers Cell Adhesion Molecule Expression Through a Mechanism Involving Activation of Nuclear Factor-κB and Activating Protein-1
B. Oertli,
B. Beck-Schimmer,
X. Fan,
R. Wüthrich
|
7 |
1998 |
7
🐢
|
|
🐜
|
Chronic norovirus infection after kidney transplantation: molecular evidence for immune-driven viral evolution.
8 auth.
R. Schorn,
M. Höhne,
A. Meerbach,
W. Bossart,
R. Wüthrich,
E. Schreier,
...
N. Müller,
T. Fehr
|
7 |
2010 |
7
🐜
|
|
🐜
|
Use of phosphate-binding agents is associated with a lower risk of mortality.
27 auth.
J. Cannata-Andía,
J. Fernández-Martín,
F. Locatelli,
G. London,
J. Górriz,
J. Floege,
M. Ketteler,
Aníbal Ferreira,
A. Covic,
B. Rutkowski,
D. Memmos,
Willem-Jan W. Bos,
V. Teplan,
J. Nagy,
C. Tielemans,
...
D. Verbeelen,
D. Goldsmith,
R. Kramar,
Pierre-Yves Martin,
R. Wüthrich,
D. Pavlović,
M. Benedik,
J. E. Sanchez,
P. Martínez-Camblor,
M. Naves-Diaz,
J. Carrero,
C. Zoccali
|
7 |
2013 |
7
🐜
|
|
🐜
|
Increases in kidney volume in autosomal dominant polycystic kidney disease can be detected within 6 months.
10 auth.
A. Kistler,
Diane Poster,
F. Krauer,
D. Weishaupt,
Shagun Raina,
O. Senn,
...
I. Binet,
K. Spanaus,
R. Wüthrich,
A. Serra
|
7 |
2009 |
7
🐜
|
|
🐜
|
Five‐Year Outcomes in Kidney Transplant Patients Converted From Cyclosporine to Everolimus: The Randomized ZEUS Study
13 auth.
K. Budde,
F. Lehner,
C. Sommerer,
P. Reinke,
W. Arns,
U. Eisenberger,
R. Wüthrich,
A. Mühlfeld,
K. Heller,
M. Porstner,
...
J. Veit,
E. Paulus,
O. Witzke
|
6 |
2015 |
6
🐜
|
|
🐢
|
Time course of serial cystatin C levels in comparison with serum creatinine after application of radiocontrast media.
8 auth.
H. Rickli,
K. Benou,
P. Ammann,
T. Fehr,
H. Rocca,
H. Petridis,
...
W. Riesen,
R. Wüthrich
|
6 |
2004 |
6
🐢
|
